1. Xu, Junjie, Ji, Lin, Ruan, Yeling, Liang, Xiao, Cai, Xiujun. 2021. UBQLN1 mediates sorafenib resistance through regulating mitochondrial biogenesis and ROS homeostasis by targeting PGC1β in hepatocellular carcinoma. In Signal transduction and targeted therapy, 6, 190. doi:10.1038/s41392-021-00594-4. https://pubmed.ncbi.nlm.nih.gov/34001851/
2. Zhou, Haoxian, Xie, Chen, Xie, Yujie, Zhao, Yong, Liu, Haiying. 2023. UBQLN1 deficiency mediates telomere shortening and IPF through interacting with RPA1. In PLoS genetics, 19, e1010856. doi:10.1371/journal.pgen.1010856. https://pubmed.ncbi.nlm.nih.gov/37463174/
3. Zhao, Shuang, Li, Jie, Duan, Songqi, Sun, Baofa, Liu, Lin. 2024. UBQLN1 links proteostasis and mitochondria function to telomere maintenance in human embryonic stem cells. In Stem cell research & therapy, 15, 180. doi:10.1186/s13287-024-03789-y. https://pubmed.ncbi.nlm.nih.gov/38902824/
4. Shah, Parag P, Saurabh, Kumar, Kurlawala, Zimple, Siskind, Leah J, Beverly, Levi J. 2022. Towards a molecular understanding of the overlapping and distinct roles of UBQLN1 and UBQLN2 in lung cancer progression and metastasis. In Neoplasia (New York, N.Y.), 25, 1-8. doi:10.1016/j.neo.2021.11.010. https://pubmed.ncbi.nlm.nih.gov/35063704/
5. Kurlawala, Zimple, Shah, Parag P, Shah, Charmi, Beverly, Levi J. 2017. The STI and UBA Domains of UBQLN1 Are Critical Determinants of Substrate Interaction and Proteostasis. In Journal of cellular biochemistry, 118, 2261-2270. doi:10.1002/jcb.25880. https://pubmed.ncbi.nlm.nih.gov/28075048/
6. González-Pérez, Paloma, Lu, Yubing, Chian, Ru-Ju, Gao, Fen-Biao, Brown, Robert H. 2012. Association of UBQLN1 mutation with Brown-Vialetto-Van Laere syndrome but not typical ALS. In Neurobiology of disease, 48, 391-8. doi:10.1016/j.nbd.2012.06.018. https://pubmed.ncbi.nlm.nih.gov/22766032/